StockData

Accendra Health vs Henry Schein

ACH and HSIC side by side, both in professional and commercial equipment and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How ACH and HSIC compare

Henry Schein is the larger company, worth 961 times as much as Accendra Health ($9.6B against $10.0M).

Henry Schein grew revenue faster over the last twelve months (6.5% versus −7.1% for Accendra Health).

Henry Schein keeps more of each dollar of sales as profit, with a net margin of 3.0% compared with −6.7% at Accendra Health.

Henry Schein scores higher on the StockData Score (6 against 5 for Accendra Health), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricACHHSIC
Size and price
Market cap$10.0M$9.6B
Share price$0.130$86.22
Change, 1 year−95.6%18.4%
Change, 5 years−99.7%13.2%
Employees6,50025K
StockData Score
Total score56 (better)
Valuation score4 (better)0
Growth score02 (better)
Performance score12 (better)
Health score02 (better)
Dividend score00
Valuation
P/E–25.1×
P/S0.0× (better)0.7×
P/B–3.0×
EV/EBITDA7.4× (better)13.5×
P/FCF–16.9×
FCF yield−1992%5.9% (better)
Fair value$8.62$70.12
Margin of safety98.5% (better)−23.0%
Growth
Revenue growth (TTM)−7.1%6.5% (better)
Revenue growth, 5Y average−20.1%5.4% (better)
Net income growth (TTM)–3.6%
EPS growth (TTM)–10.3%
EPS growth, 5Y average–3.0%
Profitability
Gross margin44.1% (better)31.3%
Operating margin0.17%5.0% (better)
Net margin−6.7%3.0% (better)
FCF margin−7.8%4.2% (better)
Return on equity–12.2%
Return on invested capital0.24%8.1% (better)
Financial health
Debt / equity–1.10
Net debt / EBITDA7.353.28 (better)
Interest coverage0.0×4.3× (better)
Current ratio0.411.32 (better)
Altman Z-score0.202.77 (better)
Piotroski F-score25 (better)
Dividends and buybacks
Buyback yield–7.6%
Shareholder yield0.00%7.6% (better)
Ownership
Held by institutions81.1%110%
Held by insiders21.4%18.0%
Insider net buying, 12 months–−$7.9M
Superinvestors holding–1
Short interest, % of float16.8%10.2%

Go deeper

Other comparisons

For information only, not investment advice. Check the source filings before relying on any figure.